Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Ischemic Heart Disease

Free Subscription Articles published in Cardiovasc Res Retrieve available abstracts of 69 articles: HTML format

Single Articles

March 2026
1. ESPE EKS, Louch WE, Smith GL, Stokke MK, et al
   The border zone after myocardial infarction: clarification of terminology and proposal for a new definition.
   Cardiovasc Res. 2026;122:297-300.
   PubMed    
   
   
   
2. STEIN CS, Zhang X, Witmer NH, Pennington ER, et al
   Mitoregulin supports mitochondrial membrane integrity and protects against cardiac ischaemia-reperfusion injury.
   Cardiovasc Res. 2026;122:379-396.
   PubMed     Abstract available
   
   
   
3. SUN X, Feng Y, Zhao Y, Cai Y, et al
   Maresin 1 ameliorates myocardial ischaemia?reperfusion injury by promoting tissue resident macrophage efferocytosis.
   Cardiovasc Res. 2026;122:397-411.
   PubMed     Abstract available
   
   
   
4. MORALES-CANO D, Sharysh D, Albarran-Juarez J, de Molina A, et al
   Fibroblast-like cells accumulate late in human coronary atherosclerosis contributing to necrotic core formation.
   Cardiovasc Res. 2026;122:336-348.
   PubMed     Abstract available
   
   
   
5. BAJAJ R, Huang X, Alves-Kotzev N, Weyers JJ, et al
   Deep learning-based plaque characterization in hybrid IVUS-OCT images is superior to single-modality deep learning analysis and human experts: head-to-head comparison against histology.
   Cardiovasc Res. 2026;122:245-257.
   PubMed     Abstract available
   
   
   
6. KONDO Y, Koga JI, Orkhonselenge N, Wang L, et al
   Drp1-mediated mitochondrial fission protects macrophages from mtDNA/ZBP1-mediated inflammation and inhibits post-infarct cardiac remodelling.
   Cardiovasc Res. 2026;122:214-229.
   PubMed     Abstract available
   
   
   
7. WANG T, Chen XZ, Xu HF, Wang JX, et al
   MCPPIR promotes cardiomyocyte proliferation and cardiac repair via o8G oxidation of POC1B mRNA.
   Cardiovasc Res. 2026;122:270-284.
   PubMed     Abstract available
   
   
   February 2026
8. LEADER JH, Vilahur G, Ajjan RA, Kanji R, et al
   Relationship between body mass index and endogenous fibrinolytic status in 600 patients with ST-elevation myocardial infarction.
   Cardiovasc Res. 2026 Feb 27:cvag047. doi: 10.1093.
   PubMed    
   
   
   
9. FISCHER M, Sigle M, Manke MC, Marzi J, et al
   Platelet Casein Kinase 2alpha is a pivotal player in arterial thrombotic occlusion and post-ischemic myocardial remodeling.
   Cardiovasc Res. 2026;122:132-145.
   PubMed     Abstract available
   
   
   
10. LI W, Zhou S, Liu J, Luo L, et al
    Identification of ALDH1A2-mediated cardioprotective benefits in myocardial ischaemia-reperfusion injury.
    Cardiovasc Res. 2026;121:2922-2938.
    PubMed     Abstract available
    
    
    
11. GUO Z, Li L, Luo J, Xue W, et al
    The Ets2 super-enhancer modulates endothelial-mesenchymal transition during cardiac ageing.
    Cardiovasc Res. 2026;121:2892-2908.
    PubMed     Abstract available
    
    
    January 2026
12. QUINTAVALLE C, Roscigno G, Petrillo G, Paolucci L, et al
    Proteomic profiling of extracellular vesicles in ST-elevation acute myocardial infarction.
    Cardiovasc Res. 2026 Jan 30:cvag033. doi: 10.1093.
    PubMed    
    
    
    
13. LI Y, Al Rimon R, Wang F, Li H, et al
    Temporal inhibition of ADAM17 in fibroblasts reduces stiffness and promotes vascularization following myocardial infarction.
    Cardiovasc Res. 2026 Jan 12:cvaf256. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2025
14. ZHANG Y, Xiao T, Ding J, Jin H, et al
    Targeting olfactory receptor 2 on monocytes for cardioprotection against myocardial ischaemia-reperfusion injury via NR4A1-mediated mitochondrial fission.
    Cardiovasc Res. 2025;121:2759-2776.
    PubMed     Abstract available
    
    
    November 2025
15. HE M, Tay WT, Song N, Liu T, et al
    Cardioprotective role of RBFox1 in myocardial infarction-induced heart failure.
    Cardiovasc Res. 2025 Nov 26:cvaf206. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. CHEN Q, Liu J, Madonna R, Li F, et al
    Vasostatin-2 attenuates injury-induced neointimal hyperplasia through the ACE2/MasR/PPARgamma/NR1D1/Gas1 axis.
    Cardiovasc Res. 2025;121:2260-2277.
    PubMed     Abstract available
    
    
    
17. TAYLOR DJ, Saxton H, Xu X, Yones E, et al
    Invasive validation of novel 1D models for computation of coronary fractional flow reserve.
    Cardiovasc Res. 2025;121:2233-2245.
    PubMed     Abstract available
    
    
    
18. ZHANG Y, Dong Q, Bian X, Qiao Z, et al
    Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion.
    Cardiovasc Res. 2025 Nov 12:cvaf223. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. BUGIARDINI R, Rahaman T, Manfrini O, Maas A, et al
    Diet and sex inequities in ischemic heart disease mortality across Europe: findings from the global burden of disease study.
    Cardiovasc Res. 2025 Nov 3:cvaf176. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2025
20. NOONAN J, Prijaya SA, Bienvenu LA, Dayawansa NH, et al
    CTLA-4-Ig therapy preserves cardiac function following myocardial infarction with reperfusion.
    Cardiovasc Res. 2025 Oct 3:cvaf165. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2025
21. GOLFOROUSH P, Sulaiman E, He D, Yellon DM, et al
    An activator of phosphatidylinositol 3-kinase alpha restores cardioprotection from ischaemia/reperfusion injury in mice with coronary atherosclerosis or insulin resistance.
    Cardiovasc Res. 2025;121:1722-1733.
    PubMed     Abstract available
    
    
    
22. REILLY-O'DONNELL B, Ferraro E, Brody R, Tikhomirov R, et al
    Protective effect of ursodeoxycholic acid upon the post-myocardial infarction heart.
    Cardiovasc Res. 2025 Sep 12:cvaf133. doi: 10.1093.
    PubMed    
    
    
    August 2025
23. VOLPE M, Gallo G, Guzik TJ, Williams B, et al
    Blood pressure management in secondary prevention after myocardial infarction.
    Cardiovasc Res. 2025 Aug 26:cvaf145. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. HADAYA J, Boukens BJD, Janse MJ, Cha S, et al
    Right stellate ganglion stimulation modulates arrhythmogenesis in acute left lateral ventricular ischaemia.
    Cardiovasc Res. 2025;121:1385-1391.
    PubMed     Abstract available
    
    
    
25. GUTMANN C, Barwari T, Schulte C, Theofilatos K, et al
    Platelets and inflammation-insights from platelet non-coding RNA content and release in the Bruneck study and the PACMAN-AMI trial.
    Cardiovasc Res. 2025;121:1392-1406.
    PubMed     Abstract available
    
    
    
26. STAPMANNS P, Abdelwahed YS, Wolfram C, Strassler E, et al
    Novel flow cytometry-based method for isolating and characterizing human coronary artery endothelial cells from catheter wires in coronary disease and microvascular dysfunction.
    Cardiovasc Res. 2025 Aug 9:cvaf139. doi: 10.1093.
    PubMed    
    
    
    July 2025
27. LARSSON I, Sun J, Ahmad S, Bergstrom G, et al
    Low-fibre diet is associated with high-risk coronary plaque features.
    Cardiovasc Res. 2025;121:1204-1214.
    PubMed     Abstract available
    
    
    
28. ABALLO TJ, Bae J, Paltzer WG, Chapman EA, et al
    Integrated proteomics identifies troponin I isoform switch as a regulator of a sarcomere-metabolism axis during cardiac regeneration.
    Cardiovasc Res. 2025;121:1240-1253.
    PubMed     Abstract available
    
    
    June 2025
29. NGUYEN TQ, Vlasenko D, Shetty AN, Zhao E, et al
    Systematic review and meta-analysis of respiratory viral triggers for acute myocardial infarction and stroke.
    Cardiovasc Res. 2025 Jun 17:cvaf092. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. MYLONAS N, Siokatas G, Zacharia E, Pol C, et al
    Cardiac ischaemia/reperfusion in pigs and mice increases cardiomyocyte Kruppel-like factor 5 that aggravates tissue injury and remodelling.
    Cardiovasc Res. 2025;121:900-914.
    PubMed     Abstract available
    
    
    
31. ZHANG S, Xiang B, Zhao Y, Wang W, et al
    Single-cell epigenomic and transcriptomic analysis unveils the pivotal role of GATA5/ISL1+ fibroblasts in cardiac repair post-myocardial infarction.
    Cardiovasc Res. 2025 Jun 3:cvaf101. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2025
32. CHEN Q, Yu Y, Tong L, Weiss RM, et al
    Targeted delivery of TAPI-1 via biomimetic nanoparticles ameliorates post-infarct left ventricle function and remodelling.
    Cardiovasc Res. 2025;121:760-774.
    PubMed     Abstract available
    
    
    
33. TALABIEKE S, Yang X, Yang J, Wan Q, et al
    Arachidonic acid synergizes with aspirin preventing myocardial ischaemia-reperfusion injury and mitigates bleeding risk.
    Cardiovasc Res. 2025;121:775-787.
    PubMed     Abstract available
    
    
    April 2025
34. AHMAD H, Gopakumar J, Nachun DC, Ma L, et al
    Single cell RNA sequencing of haematopoietic cells in fresh and frozen human atheroma tissue.
    Cardiovasc Res. 2025;121:396-404.
    PubMed     Abstract available
    
    
    
35. BONACINA F, Carnevale D
    Sleep protects the heart after myocardial infarction through a neuro-immune axis: time to implement healthy sleep for cardiovascular prevention?
    Cardiovasc Res. 2025 Apr 23:cvaf073. doi: 10.1093.
    PubMed    
    
    
    
36. DARWESH AM, Fang L, Altamimi TR, Jamieson KL, et al
    Cardioprotective effect of 19,20-epoxydocosapentaenoic acid (19,20-EDP) in ischaemic injury involves direct activation of mitochondrial sirtuin 3.
    Cardiovasc Res. 2025;121:267-282.
    PubMed     Abstract available
    
    
    
37. ZHANG W, Zhang Y, Han L, Bo T, et al
    Double-stranded DNA enhances platelet activation, thrombosis, and myocardial injury via cyclic GMP-AMP synthase.
    Cardiovasc Res. 2025;121:353-366.
    PubMed     Abstract available
    
    
    
38. ROSLAN A, Paulus K, Yang J, Matt L, et al
    Slack K+ channels confer protection against myocardial ischaemia/reperfusion injury.
    Cardiovasc Res. 2025;121:174-189.
    PubMed     Abstract available
    
    
    
39. DALKARA T, Ostergaard L, Heusch G, Attwell D, et al
    Pericytes in the brain and heart: functional roles and response to ischaemia and reperfusion.
    Cardiovasc Res. 2025;120:2336-2348.
    PubMed     Abstract available
    
    
    February 2025
40. CHEN M, Zhao N, Shi W, Xing Y, et al
    Glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist tirzepatide promotes branched chain amino acid catabolism to prevent myocardial infarction in non-diabetic mice.
    Cardiovasc Res. 2025 Feb 10:cvaf005. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. SHANG R, Rodrigues B
    Cardioprotective effects of a 'twincretin' drug tirzepatide in heart failure following myocardial infarction.
    Cardiovasc Res. 2025 Feb 4:cvaf006. doi: 10.1093.
    PubMed    
    
    
    January 2025
42. VILAHUR G, Ben-Aicha S, Gutierrez M, Radike M, et al
    Cardioprotection exerted by intravenous statin at index myocardial infarction event attenuates cardiac damage upon recurrent infarction.
    Cardiovasc Res. 2025 Jan 3:cvae264. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2024
43. FABIN N, Cenko E, Bergami M, Yoon J, et al
    Early coronary revascularization among 'stable' patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age.
    Cardiovasc Res. 2024;120:2064-2077.
    PubMed     Abstract available
    
    
    
44. TANG XL, Wysoczynski M, Gumpert AM, Solanki M, et al
    Intravenous infusions of mesenchymal stromal cells have cumulative beneficial effects in a porcine model of chronic ischaemic cardiomyopathy.
    Cardiovasc Res. 2024;120:1939-1952.
    PubMed     Abstract available
    
    
    
45. TAN J, Min J, Jiang Y, Liu S, et al
    CircCHSY1 protects hearts against ischaemia/reperfusion injury by enhancing heme oxygenase 1 expression via miR-24-3p.
    Cardiovasc Res. 2024;120:1924-1938.
    PubMed     Abstract available
    
    
    November 2024
46. AHERRAHROU R, Reinberger T, Hashmi S, Erdmann J, et al
    GWAS breakthroughs: mapping the journey from one locus to 393 significant coronary artery disease associations.
    Cardiovasc Res. 2024;120:1508-1530.
    PubMed     Abstract available
    
    
    
47. PAN Z, Lv J, Zhao L, Xing K, et al
    CircARCN1 aggravates atherosclerosis by regulating HuR-mediated USP31 mRNA in macrophages.
    Cardiovasc Res. 2024;120:1531-1549.
    PubMed     Abstract available
    
    
    
48. ZHANG LJ, Hu YX, Huang RZ, Xu YY, et al
    Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition.
    Cardiovasc Res. 2024;120:1622-1635.
    PubMed     Abstract available
    
    
    October 2024
49. WANG YJ, Matter CM
    Histone deacetylase 6 suppression protects from myocardial ischaemia-reperfusion injury in diabetes: insights from genetic deletion and pharmacological inhibition.
    Cardiovasc Res. 2024;120:1369-1371.
    PubMed    
    
    
    
50. BAUMGARDT SL, Fang J, Fu X, Liu Y, et al
    Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes.
    Cardiovasc Res. 2024;120:1456-1471.
    PubMed     Abstract available
    
    
    September 2024
51. YANG R, Ruan B, Wang R, Zhang X, et al
    Cardiomyocyte betaII spectrin plays a critical role in maintaining cardiac function by regulating mitochondrial respiratory function.
    Cardiovasc Res. 2024;120:1312-1326.
    PubMed     Abstract available
    
    
    
52. HEIANZA Y, Wang X, Kou M, Tiwari S, et al
    Circulating dimethylguanidino valeric acid, dietary factors, and risk of coronary heart disease.
    Cardiovasc Res. 2024 Sep 7:cvae199. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2024
53. PSALTIS PJ, Nguyen MT, Singh K, Sinhal A, et al
    Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction.
    Cardiovasc Res. 2024 Aug 27:cvae191. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. VAN OORTMERSSEN JAE, Ntlapo N, Tilly MJ, Bramer WM, et al
    Burden of risk factors in women and men with unrecognised myocardial infarction: a systematic review and meta-analysis.
    Cardiovasc Res. 2024 Aug 27:cvae188. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2024
55. HU M, Zhang X, Hu C, Ma ZG, et al
    Isthmin-1 alleviates cardiac ischaemia/reperfusion injury through cGMP-PKG signalling pathway.
    Cardiovasc Res. 2024;120:1051-1064.
    PubMed     Abstract available
    
    
    
56. KUFAZVINEI TTJ, Chai J, Boden KA, Channon KM, et al
    Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes.
    Cardiovasc Res. 2024 Jul 19:cvae142. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. COLEMAN JA, Doste R, Ashkir Z, Coppini R, et al
    Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.
    Cardiovasc Res. 2024;120:914-926.
    PubMed     Abstract available
    
    
    
58. FU L, Du J, Furkert D, Shipton ML, et al
    Depleting inositol pyrophosphate 5-InsP7 protected the heart against ischaemia-reperfusion injury by elevating plasma adiponectin.
    Cardiovasc Res. 2024;120:954-970.
    PubMed     Abstract available
    
    
    June 2024
59. PHAM QH, Bui TVA, Sim WS, Lim KH, et al
    Daily oral administration of probiotics engineered to constantly secrete short-chain fatty acids effectively prevents myocardial injury from subsequent ischemic heart disease.
    Cardiovasc Res. 2024 Jun 8:cvae128. doi: 10.1093.
    PubMed     Abstract available
    
    
    
60. GRECO CM, Nisoli E
    The ketogenic diet is unable to improve cardiac function in ischemic heart failure: an unexpected result?
    Cardiovasc Res. 2024 Jun 6:cvae126. doi: 10.1093.
    PubMed    
    
    
    May 2024
61. SUGIYAMA T, Jang IK
    Is cutting-edge imaging technology superior to conventional angiography in improving outcomes of coronary artery stenting?
    Cardiovasc Res. 2024;120:e17-e19.
    PubMed    
    
    
    
62. HO KL, Karwi Q, Wang F, Wagg C, et al
    The ketogenic diet does not improve cardiac function and blunts glucose oxidation in ischemic heart failure.
    Cardiovasc Res. 2024 May 1:cvae092. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2024
63. MEHDIZADEH M, Naud P, Abu-Taha IH, Hiram R, et al
    The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology.
    Cardiovasc Res. 2024;120:506-518.
    PubMed     Abstract available
    
    
    
64. SUN Q, Chen W, Wu R, Tao B, et al
    Serine protease inhibitor, SerpinA3n regulates cardiac remodeling after myocardial infarction.
    Cardiovasc Res. 2024 Apr 26:cvae075. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
65. KIZER JR
    The elusive quest for causality in adiponectin's bimodal relationship with cardiovascular disease: Mendelian randomization meets Janus.
    Cardiovasc Res. 2024;120:3-5.
    PubMed    
    
    
    
66. DE WIT S, Geerlings L, Shi C, Dronkers J, et al
    Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice.
    Cardiovasc Res. 2024 Feb 24:cvae038. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. TORIMOTO K, Elliott K, Nakayama Y, Yanagisawa H, et al
    Cardiac and perivascular myofibroblasts, matrifibrocytes, and immune fibrocytes in hypertension; commonalities and differences with myocardial infarction and other cardiovascular diseases.
    Cardiovasc Res. 2024 Feb 23:cvae044. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
68. ABOULEISA RRE, Tang XL, Ou Q, Salama AM, et al
    Gene therapy encoding cell cycle factors to treat chronic ischemic heart failure in rats.
    Cardiovasc Res. 2024 Jan 4:cvae002. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2023
69. HIRAM R, Xiong F, Naud P, Xiao J, et al
    An inflammation resolution-promoting intervention prevents atrial fibrillation due to left-ventricular dysfunction.
    Cardiovasc Res. 2023 Dec 13:cvad175. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum